Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AVE-1231 is an inhibitor of two-pore domain potassium channel 3.1 (K2P3.1), also known as TWIK-related acid-sensitive potassium channel (TASK1).1 It reduces potassium currents in X. laevis oocytes expressing TASK1 (IC50 = 0.22 µM) but also those expressing voltage-gated potassium channel 1.5 (Kv1.5; IC50 = 5.6 µM).2 AVE-1231 (1 mg/kg) restores sinus rhythm in a porcine model of acute paroxysmal atrial fibrillation.3 It also reduces the severity of experimental autoimmune encephalomyelitis (EAE) in wild-type mice but not TASK1 knockout mice when administered at a dose of 0.02 mg/kg.4
WARNING This product is not for human or veterinary use.
1. TWIK-
2. Kv1.5 blockers preferentially inhibit TASK-
3. Pharmacologic TWIK-
4. The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis. Exp. Neurol. 238(2), 149-155 (2012).